We studied the protein expression level of p14ARF and p16INK4a by immunohistochemistry on papillary carcinomas (n=15), follicular adenomas (n=10) and follicular carcinomas (n=5). This evidence concerns the gene CDKN2A and thyroid gland follicular carcinoma.